Posted by Michael Wonder on 26 Apr 2021
EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe
26 April 2021 - The EMA and the European Centre for Disease Prevention and Control today kicked off a new initiative aimed at strengthening post-marketing monitoring of the safety, effectiveness and impact of COVID-19 vaccines in the European Union and the European Economic Area.
With the ongoing authorisation and rollout of several COVID-19 vaccines in the European Union, jointly coordinated, large-scale, EU wide effectiveness and safety studies are an essential tool to closely monitor how these novel vaccines perform in real life.
